by Sumi Park, Ji Man Han, Jun Cheon, Jong-Ik Hwang, Jae Young Seong Gonadotropin-releasing hormone-I (GnRH-I) has attracted strong attention as a hormonal therapeutic tool, particularly for androgen-dependent prostate cancer patients. Here, we investigated the effect of SN09-2 on the growth of PC3 prostate cancer cells.

READ FULL ARTICLE Curated publisher From PLOS ONE